Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Timber Pharmaceuticals Inc (NY: TMBR )

1.340 -0.070 (-4.96%)
Official Closing Price Updated: 8:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 41,105
Open 1.330
Bid (Size) 1.330 (4)
Ask (Size) 1.440 (7)
Prev. Close 1.410
Today's Range 1.330 - 1.390
52wk Range 0.0610 - 3.390
Shares Outstanding 3,044,484
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-43.22%
-43.22%
1 Month
-3.60%
-3.60%
3 Month
-57.32%
-57.32%
6 Month
-1.47%
-1.47%
1 Year
+354.24%
+354.24%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology
Via NewMediaWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Dow Dips 350 Points; S&P 500 Down Over 1%
Via Benzinga
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Timber Pharmaceuticals (NYSE American: TMBR) Granted Orphan Drug Designation in Europe for TMB-001
Via Spotlight Growth
Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher
Via Benzinga
Why Is Timber Pharmaceuticals (TMBR) Stock Up 61% Today?
Via InvestorPlace
Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis
Via NewMediaWire
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward Outlook
Via NewMediaWire
Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards
Via NewMediaWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results
Via NewMediaWire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock Split
Via NewMediaWire
Timber Pharmaceuticals Announces Halt of Common Stock Trading
Via NewMediaWire
Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive Ichthyosis
Via NewMediaWire
Nasdaq Jumps 270 Points; Silver Surges Over 8%
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.